Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700838 · ClinicalTrials.gov registry record · Phase 1
Refining Cough Skill Training in Parkinson's Disease and Dysphagia
A Phase 1 study, sponsored by Teachers College, Columbia University.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT05700838: Completed Phase 1 study, sponsored by Teachers College, Columbia University.
NCT05700838 is a Phase 1 study that has completed, run by Teachers College, Columbia University. The registered enrollment target is 23 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05700838, a Phase 1 study, has completed, sponsored by Teachers College, Columbia University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
Airway protection deficits (cough and swallowing) are prevalent and pervasive in Parkinson's disease (PD), contributing to adverse health outcomes like pneumonia. This study aims to refine cough skill training by examining whether variable versus constant practice conditions improve cough outcomes in people with PD. In addition, this study will provide insight into optimal respiratory adaptations that occur during training to support cough effectiveness, resulting in immediately translatable treatments to improve airway protection-related health outcomes in people with neurodegenerative disease.
Primary Outcome
Cough Strength
Interventions
- BEHAVIORAL Cough Skill Training - with Variable Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2023-06-28 |
| Phase | Phase 1 |
What the finished NCT05700838 record still lists
NCT05700838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 1 intervention - of which Cough Skill Training - with Variable Practice is the first listed.
NCT05700838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05700838 about?
NCT05700838 is a clinical study titled "Refining Cough Skill Training in Parkinson's Disease and Dysphagia". Airway protection deficits (cough and swallowing) are prevalent and pervasive in Parkinson's disease (PD), contributing to adverse health outcomes like pneumonia. This study aims to refine cough skill training by examining whether variable versus constant practice conditions improve cough outcomes i...
What is the current status of trial NCT05700838?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2022-09-21. Estimated completion is 2023-06-28.
What interventions are being tested in trial NCT05700838?
The interventions under investigation include: Cough Skill Training - with Variable Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05700838?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05700838's enrollment target sits among peer trials
23 1596th of 2000 higher than 400 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI